(ATTN: UPDATES with Samsung C&T's release in last four paras) SEOUL, June 28 (Yonhap) -- Ilsung Pharmaceutical, a South Korean drugmaker with a 2.11 percent stake in Samsung C&T Co., said Sunday that Samsung Group's bid to merge its construction and t
